pentobarbital will reduce the extent or impact of linagliptin by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe. Use of different treatment plans is strongly suggested when linagliptin is to be administered having a CYP3A4 inducerpentobarbital will lower the extent or outcome of ethotoin by influencing hepatic enzyme CYP